Cite
HARVARD Citation
Galeazzi, M. et al. (n.d.). OP0099 Safety, tolerability and initial signs of efficacy of the fully human immunocytokine DEKAVIL (F8IL10): a novel therapeutic approach for rheumatoid arthritis. Annals of the rheumatic diseases. pp. 92-93. [Online].